Regeneron's 'Champion Of Cancer Vaccines' Forges New Path
An Interview With Raquel Deering, Associate Director Of Immuno-Oncology At Regeneron
Executive Summary
Raquel Deering, one of In Vivo's 2020 Rising Leaders, discusses Regeneron's efforts to develop combination therapies, its collaborations with cancer vaccine companies, and its plans to become a major force in the oncology field.